- Home
- ANVS vs VATE Comparison
ANVS vs VATE Comparison
Compare ANVS & VATE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ANVS
- VATE
- Stock Information
- Founded
- ANVS 2008
- VATE 1994
- Country
- ANVS United States
- VATE United States
- Employees
- ANVS N/A
- VATE N/A
- Industry
- ANVS Biotechnology: Pharmaceutical Preparations
- VATE Metal Fabrications
- Sector
- ANVS Health Care
- VATE Industrials
- Exchange
- ANVS Nasdaq
- VATE Nasdaq
- Market Cap
- ANVS 44.6M
- VATE 98.2M
- IPO Year
- ANVS 2020
- VATE 1996
- Fundamental
- Price
- ANVS $2.36
- VATE $5.45
- Analyst Decision
- ANVS Strong Buy
- VATE
- Analyst Count
- ANVS 4
- VATE 0
- Target Price
- ANVS $18.00
- VATE N/A
- AVG Volume (30 Days)
- ANVS 485.7K
- VATE 18.5K
- Earning Date
- ANVS 08-14-2025
- VATE 08-06-2025
- Dividend Yield
- ANVS N/A
- VATE N/A
- EPS Growth
- ANVS N/A
- VATE N/A
- EPS
- ANVS N/A
- VATE N/A
- Revenue
- ANVS N/A
- VATE $1,066,100,000.00
- Revenue This Year
- ANVS N/A
- VATE N/A
- Revenue Next Year
- ANVS N/A
- VATE N/A
- P/E Ratio
- ANVS N/A
- VATE N/A
- Revenue Growth
- ANVS N/A
- VATE N/A
- 52 Week Low
- ANVS $1.11
- VATE $3.25
- 52 Week High
- ANVS $17.88
- VATE $13.79
- Technical
- Relative Strength Index (RSI)
- ANVS 48.29
- VATE 49.75
- Support Level
- ANVS $2.05
- VATE $5.04
- Resistance Level
- ANVS $3.18
- VATE $5.37
- Average True Range (ATR)
- ANVS 0.26
- VATE 0.24
- MACD
- ANVS -0.08
- VATE 0.06
- Stochastic Oscillator
- ANVS 27.43
- VATE 89.66
About ANVS Annovis Bio Inc.
Annovis Bio Inc is a clinical-stage pharmaceutical company focused on developing and commercializing drugs for the treatment of Parkinson's and Alzheimer's diseases and other neurodegenerative diseases. The pipeline products of the company consists of: Buntanetap for chronic neurodegeneration - including AD and PD; ANVS405 for acute neurodegeneration; and ANVS301 for AD.
About VATE INNOVATE Corp.
Innovate Corp is a diversified holding company that has a portfolio of subsidiaries in a variety of operating segments which are; The infrastructure segment is comprised of DBM Global Inc, a fully integrated industrial construction, structural steel, and facility maintenance provider that provides fabrication and erection of structural steel and heavy steel plate services, The Life Sciences segment is comprised of Pansend Life Sciences which seeks to develop products to treat early osteoarthritis of the knee and aesthetic and medical technologies for the skin, and Spectrum segment is comprised of HC2 Broadcasting Holdings Inc which operates over-the-air broadcasting station across the United States.